Peripheral Blood Mononuclear Cells: A New Frontier in the Management of Patients with Diabetes and No-Option Critical Limb Ischaemia

The current study aimed to evaluate the effectiveness of peripheral blood mononuclear cell (PB-MNC) therapy as adjuvant treatment for patients with diabetic foot ulcers (DFUs) and no-option critical limb ischaemia (NO-CLI). The study is a prospective, noncontrolled, observational study including pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Meloni, Marco, Giurato, Laura, Andreadi, Aikaterini, Bellizzi, Ermanno, Bellia, Alfonso, Lauro, Davide, Uccioli, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573900/
https://www.ncbi.nlm.nih.gov/pubmed/37834766
http://dx.doi.org/10.3390/jcm12196123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573900/
https://www.ncbi.nlm.nih.gov/pubmed/37834766
http://dx.doi.org/10.3390/jcm12196123

Ejemplares similares